Literature DB >> 9935048

Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation.

M Schäfers1, T Wichter, H Lerch, P Matheja, T Kuwert, K Schäfers, M Borggrefe, G Breithardt, O Schober.   

Abstract

UNLABELLED: Patients with idiopathic ventricular tachycardia or fibrillation have no additional structural or functional myocardial abnormalities. However, the inducibility of typical tachyarrhythmias by physical or mental stress or by catecholamine infusion suggests the involvement of the adrenergic system in the pathogenesis of these potentially life-threatening diseases.
METHODS: 45 patients with idiopathic right ventricular outflow tract tachycardia (RVO-VT), 25 patients with idiopathic left ventricular tachycardia (ILVT), 15 patients with idiopathic ventricular fibrillation (IVF) and 10 age-matched control patients were investigated in this study. Diagnoses were made on the basis of detailed evaluation of the results of two-dimensional echocardiography, left and right ventricular angiography, coronary angiography and endomyocardial biopsy. Local presynaptic norepinephrine re-uptake was assessed using the norepinephrine analog 1231-metaiodobenzylguanidine (MIBG), SPECT and semiquantitative 33-segment bull's-eye analysis.
RESULTS: Locally reduced 123I-MIBG uptake was found in 27 of 45 RVO-VT patients (60%), 5 of 15 ILVT patients (33%) and 17 of 25 IVF patients (68%). Unlike ILVT patients, RVO-VT and IVF patients had significantly reduced segmental 123I-MIBG uptake of the posterior wall compared with control patients.
CONCLUSION: Patients with idiopathic tachycardia and fibrillation show abnormal 1231-MIBG uptake, which indicates presynaptic sympathetic dysfunction. RVO-VT and IVF patients exhibit significantly reduced 123I-MIBG uptake in the posterior left ventricular wall, whereas ILVT patients do not.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9935048

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

Review 2.  Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

Authors:  John J Mahmarian; Girish Dwivedi; Tultul Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 3.  Neurocardiology: therapeutic implications for cardiovascular disease.

Authors:  David S Goldstein
Journal:  Cardiovasc Ther       Date:  2010-11-25       Impact factor: 3.023

4.  Will innervation imaging predict ventricular arrhythmias in ischaemic cardiomyopathy?

Authors:  Maureen M Henneman; Frank M Bengel; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08       Impact factor: 9.236

Review 5.  Cardiac neuronal imaging: application in the evaluation of cardiac disease.

Authors:  Maureen M Henneman; Frank M Bengel; Ernst E van der Wall; Juhani Knuuti; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

Review 6.  Cardiac autonomic innervation.

Authors:  Hina K Jamali; Fahad Waqar; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2016-11-14       Impact factor: 5.952

7.  Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events.

Authors:  Shu Kasama; Takuji Toyama; Yoshiaki Kaneko; Toshiya Iwasaki; Hiroyuki Sumino; Hisao Kumakura; Kazutomo Minami; Shuichi Ichikawa; Naoya Matsumoto; Yuichi Sato; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-14       Impact factor: 9.236

8.  Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome.

Authors:  Peter Kies; Matthias Paul; Joachim Gerss; Lars Stegger; Gerold Mönnig; Otmar Schober; Thomas Wichter; Michael Schäfers; Eric Schulze-Bahr
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-21       Impact factor: 9.236

9.  Cardiac sympathetic nerve abnormality predicts ventricular tachyarrhythmic events in patients without conventional risk of sudden death.

Authors:  Yasushi Akutsu; Kyouichi Kaneko; Yusuke Kodama; Hui-Ling Li; Mitsuharu Kawamura; Taku Asano; Kaoru Tanno; Akira Shinozuka; Takehiko Gokan; Youichi Kobayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-12       Impact factor: 9.236

10.  Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias.

Authors:  Hidenobu Terai; Masami Shimizu; Hidekazu Ino; Masato Yamaguchi; Kenshi Hayashi; Kenji Sakata; Masaru Kiyama; Tatsumi Hayashi; Masaru Inoue; Junichi Taki; Hiroshi Mabuchi
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.